XML 45 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
STATEMENTS OF CASH FLOW (UNAUDITED) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flow from operating activities:    
Net income $ 18,795 $ 13,255
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation and amortization 57,347 40,070
Amortization of deferred loan costs 2,372 1,894
Amortization of senior notes discount 184 38
Equity-based compensation expense 5,206 2,901
Bad debt expense 640 402
Write off of deferred loan costs 83 580
Deferred tax benefit (5,695)  
Changes in operating assets and liabilities    
Rents and other receivables, net (2,382) 104
Prepaid expenses (4,713) (2,245)
Other assets (352) 596
Accounts payable and accrued liabilities (2,427) (7,833)
Advance rents, security deposits and other liabilities (437) (44)
Deferred income 3,698 1,637
Net cash provided by operating activities 72,319 51,355
Cash flow from investing activities:    
Acquisitions, net of cash acquired (288,865) (91,064)
Additions to property and equipment (252,156) (156,008)
Cash used in investing activities (541,021) (247,072)
Cash flow from financing activities:    
Credit facility proceeds 420,162 230,500
Senior Notes proceeds   297,633
Debt repayment (260,000) (290,000)
Payment of deferred financing costs (577) (9,648)
Payment of cash dividend (32,756) (23,783)
Distribution to noncontrolling interest (6,652) (6,932)
Principal payments on capital lease obligation (4,415) (553)
Mortgage principal debt repayments (16,600) (1,665)
Equity proceeds, net of costs 369,482  
Net cash provided by financing activities 468,644 195,552
Net decrease in cash and cash equivalents (58) (165)
Cash and cash equivalents, beginning of period 10,788 5,210
Cash and cash equivalents, end of period 10,730 5,045
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION    
Cash paid for interest (excluding deferred financing costs and amounts capitalized) 17,785 4,599
Noncash investing and financing activities:    
Accrued capital additions 48,540 36,381
Capital lease and lease financing obligations assumed 43,832  
Qualitytech, LP [Member]    
Cash flow from operating activities:    
Net income 18,795 13,255
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation and amortization 57,347 40,070
Amortization of deferred loan costs 2,372 1,894
Amortization of senior notes discount 184 38
Equity-based compensation expense 5,206 2,901
Bad debt expense 640 402
Write off of deferred loan costs 83 580
Deferred tax benefit (5,695)  
Changes in operating assets and liabilities    
Rents and other receivables, net (2,382) 104
Prepaid expenses (4,713) (2,245)
Other assets (352) 596
Accounts payable and accrued liabilities (2,427) (7,833)
Advance rents, security deposits and other liabilities (437) (44)
Deferred income 3,698 1,637
Net cash provided by operating activities 72,319 51,355
Cash flow from investing activities:    
Acquisitions, net of cash acquired (288,865) (91,064)
Additions to property and equipment (252,156) (156,008)
Cash used in investing activities (541,021) (247,072)
Cash flow from financing activities:    
Credit facility proceeds 420,162 230,500
Senior Notes proceeds   297,633
Debt repayment (260,000) (290,000)
Payment of deferred financing costs (577) (9,648)
Payment of cash dividend (32,756) (23,783)
Partnership distributions (6,652) (6,932)
Principal payments on capital lease obligation (4,415) (553)
Mortgage principal debt repayments (16,600) $ (1,665)
Equity proceeds, net of costs 369,482
Net cash provided by financing activities 468,644 $ 195,552
Net decrease in cash and cash equivalents (58) (165)
Cash and cash equivalents, beginning of period 10,788 5,210
Cash and cash equivalents, end of period 10,730 5,045
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION    
Cash paid for interest (excluding deferred financing costs and amounts capitalized) 17,785 4,599
Noncash investing and financing activities:    
Accrued capital additions 48,540 $ 36,381
Capital lease and lease financing obligations assumed $ 43,832